Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.

Thomas T. et al, (2024), Nat Immunol

Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies.

Goodday SM. et al, (2024), Journal of medical Internet research, 26

Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial

de Cates AN. et al, (2024), The British Journal of Psychiatry, 1 - 8

Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.

Griffin H. et al, (2024), The New England journal of medicine, 391, 434 - 441

Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.

Schreiber S. et al, (2024), Digestive diseases and sciences

Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitis.

Jairath V. et al, (2024), Journal of patient-reported outcomes, 8

Exclusive Enteral Nutrition Mediates Beneficial Gut Microbiome Enrichment in Acute Severe Colitis.

Bajaj A. et al, (2024), Inflammatory bowel diseases, 30, 641 - 650

Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).

Tripathi D. et al, (2024), BMJ open gastroenterology, 11

Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials.

Pai RK. et al, (2024), Expert review of gastroenterology & hepatology, 18, 73 - 87

The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis

Paridaens K. et al, (2024), Frontiers in Gastroenterology, 3

Letter: 'No first among equals'.

Arora U. et al, (2023), Alimentary pharmacology & therapeutics

Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards.

Uhlig HH. et al, (2023), Nature reviews. Gastroenterology & hepatology

Inflammation across tissues: can shared cell biology help design smarter trials?

Hosack T. et al, (2023), Nature reviews. Rheumatology

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions.

Dubinsky M. et al, (2023), The American journal of gastroenterology

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.

Travis S. et al, (2023), Inflammatory bowel diseases

JAK inhibitor, a new player for treatment-refractory microscopic colitis.

Druez A. et al, (2023), Intestinal research, 21, 411 - 412

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774

Development of the Escalation of Therapy or Intervention (ETI) calculator for patients with ulcerative colitis using ePROMS.

Matini L. et al, (2023), Journal of Crohn's & colitis

Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC).

Ventham NT. et al, (2023), Cellular and molecular gastroenterology and hepatology, 16, 431 - 450

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.

Wong S-Y. et al, (2023), Inflammatory bowel diseases

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?